Title: RS Virus Surge in Dutch Hospitals: Children‘s Wards Busy, Vaccine Hope on the Horizon
Children’s wards in Drenthe’s hospitals are feeling the pressure as young patients with Respiratory Syncytial Virus (RSV) flood in, marking the annual return of the virus that primarily affects babies and young children during the fall and winter seasons.
“We’ve seen an increase in the number of children admitted with RSV at the children’s department in Emmen for the past few weeks,” confirmed a spokesperson for Treant Zorgroep, which operates hospitals in Emmen, Hoogeveen, and Stadskanaal. “But this is no different from previous years.”
At Isala hospital in Meppel, no sick children are being admitted; they are taken to the Zwolle location. “Currently, there are 14 children in Zwolle, half of whom have RSV. This number is similar to other years. We usually see this peak around January. Last year, it started in November, so it’s a bit later this time,” stated a spokesperson.
The influx of RSV cases hasn’t affected other healthcare services. “We’re prepared through adjusting our staff schedules. The virus comes every year, so you have to be flexible,” the spokesperson reassured. In serious cases, children are transferred to the intensive care unit (ICU) in Groningen, which has happened with a few cases so far this season.
The Wilhelmina Hospital in Assen is also seeing RSV cases, with its children’s department busy but not overwhelmed. “The number of admissions aligns with the national trend. So far, we haven’t had any capacity issues or impacts on other care. If a child needs more intensive care, they’re transferred to an ICU elsewhere,” a spokesperson explained.
RSV rears its head annually around this time, posing a particular threat to premature babies, children with Down syndrome, and those with congenital heart defects. The virus can cause severe symptoms like pneumonia and breathing difficulties.
However, there’s hope on the horizon. A vaccine to prevent RSV is set to be available in the Netherlands next fall. According to the Netherlands Institute for Public Health and the Environment (RIVM), this vaccine could prevent around 80% of hospitalizations caused by RSV.
Worth a look
